Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

De Paschale M, Clerici P.

World J Virol. 2016 Aug 12;5(3):97-124. doi: 10.5501/wjv.v5.i3.97. Review.

2.

An Evaluation of Voluntary Varicella Vaccination Coverage in Zhejiang Province, East China.

Hu Y, Chen Y, Zhang B, Li Q.

Int J Environ Res Public Health. 2016 Jun 3;13(6). pii: E560. doi: 10.3390/ijerph13060560.

4.

Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Thomas CA, Shwe T, Bixler D, del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR.

Pediatr Infect Dis J. 2014 Nov;33(11):1164-8. doi: 10.1097/INF.0000000000000444.

5.

Determinants of varicella breakthrough: results of a 2012 case control study.

Tafuri S, Guerra R, Cappelli MG, Martinelli D, Prato R, Germinario C.

Hum Vaccin Immunother. 2014;10(3):667-70. Epub 2014 Jan 7.

6.
7.

Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R.

Pediatrics. 2013 Nov;132(5):e1134-40. doi: 10.1542/peds.2013-0863. Epub 2013 Oct 7.

8.

Pathogenesis and current approaches to control of varicella-zoster virus infections.

Gershon AA, Gershon MD.

Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Review.

9.

Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence.

Park CS, Kim DS, Kim KH.

Clin Exp Vaccine Res. 2013 Jul;2(2):140-3. doi: 10.7774/cevr.2013.2.2.140. Epub 2013 Jul 3.

10.

Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.

Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, Manfredi P.

PLoS One. 2013 Apr 17;8(4):e60732. doi: 10.1371/journal.pone.0060732. Print 2013.

11.

Varicella zoster virus in solid organ transplantation.

Pergam SA, Limaye AP; AST Infectious Diseases Community of Practice..

Am J Transplant. 2013 Mar;13 Suppl 4:138-46. doi: 10.1111/ajt.12107. No abstract available.

12.

Knowledge, attitudes, and practices for diagnosing breakthrough varicella in the outpatient setting.

Daskalaki I, Viner KM, Perella D, Newbern EC, Johnson CC, Watson BM.

Public Health Rep. 2012 Nov-Dec;127(6):585-90.

14.

Modelling the effects of population structure on childhood disease: the case of varicella.

Silhol R, Boƫlle PY.

PLoS Comput Biol. 2011 Jul;7(7):e1002105. doi: 10.1371/journal.pcbi.1002105. Epub 2011 Jul 21.

15.

Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel.

Liu J, Kochin BF, Tekle YI, Galvani AP.

J R Soc Interface. 2012 Jan 7;9(66):68-76. doi: 10.1098/rsif.2011.0001. Epub 2011 Jun 1.

16.

Varicella zoster virus (VZV) in solid organ transplant recipients.

Pergam SA, Limaye AP; AST Infectious Diseases Community of Practice..

Am J Transplant. 2009 Dec;9 Suppl 4:S108-15. doi: 10.1111/j.1600-6143.2009.02901.x. No abstract available.

17.

Impact of varicella vaccine on varicella-zoster virus dynamics.

Schmid DS, Jumaan AO.

Clin Microbiol Rev. 2010 Jan;23(1):202-17. doi: 10.1128/CMR.00031-09. Review.

18.

Herpes zoster (shingles) and postherpetic neuralgia.

Sampathkumar P, Drage LA, Martin DP.

Mayo Clin Proc. 2009 Mar;84(3):274-80. doi: 10.1016/S0025-6196(11)61146-4. Review.

19.

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA.

J Infect Dis. 2008 Apr 1;197(7):944-9. doi: 10.1086/529043.

20.

On the epidemiology of influenza.

Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E.

Virol J. 2008 Feb 25;5:29. doi: 10.1186/1743-422X-5-29. Review.

Supplemental Content

Support Center